| Primary |
| Hypertonic Bladder |
27.5% |
| Urinary Incontinence |
12.6% |
| Hypertension |
8.2% |
| Incontinence |
6.8% |
| Cardiac Failure |
5.8% |
| Pollakiuria |
5.3% |
| Micturition Urgency |
3.9% |
| Conjunctivitis |
2.9% |
| Hyperuricaemia |
2.9% |
| Supplementation Therapy |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
| Benign Prostatic Hyperplasia |
2.4% |
| Diabetes Mellitus |
2.4% |
| Urge Incontinence |
2.4% |
| Urinary Tract Infection |
2.4% |
| Depression |
1.9% |
| Mitral Valve Stenosis |
1.9% |
| Overactive Bladder |
1.9% |
| Dysuria |
1.4% |
| Gastritis Erosive |
1.4% |
|
| Urinary Retention |
14.6% |
| Gastrointestinal Tube Insertion |
7.3% |
| Blood Pressure Increased |
6.3% |
| Urinary Tract Infection |
6.3% |
| Vision Blurred |
6.3% |
| Dysphagia |
5.2% |
| No Adverse Event |
5.2% |
| Pollakiuria |
5.2% |
| Renal Impairment |
5.2% |
| Arthralgia |
4.2% |
| Oedema Peripheral |
4.2% |
| Vitreous Opacities |
4.2% |
| Weight Increased |
4.2% |
| Arrhythmia |
3.1% |
| Bladder Cancer |
3.1% |
| Blood Pressure Decreased |
3.1% |
| Cystitis |
3.1% |
| Death |
3.1% |
| Hallucination, Visual |
3.1% |
| Impetigo |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
18.0% |
| Drug Use For Unknown Indication |
9.0% |
| Hypertension |
9.0% |
| Urinary Incontinence |
8.0% |
| Hypertonic Bladder |
7.0% |
| Cardiac Failure |
6.0% |
| Prostate Cancer |
5.0% |
| Hyperuricaemia |
4.0% |
| Incontinence |
4.0% |
| Atrial Fibrillation |
3.0% |
| Conjunctivitis |
3.0% |
| Micturition Urgency |
3.0% |
| Pain |
3.0% |
| Parkinson's Disease |
3.0% |
| Pollakiuria |
3.0% |
| Prostate Cancer Stage Iv |
3.0% |
| Thrombosis Prophylaxis |
3.0% |
| Anxiety Disorder |
2.0% |
| Benign Prostatic Hyperplasia |
2.0% |
| Bronchitis |
2.0% |
|
| Arrhythmia |
7.7% |
| Renal Impairment |
7.7% |
| Stevens-johnson Syndrome |
7.7% |
| Urinary Retention |
7.7% |
| Vision Blurred |
7.7% |
| Weight Increased |
7.7% |
| Chest Discomfort |
3.8% |
| Confusional State |
3.8% |
| Dermatitis Psoriasiform |
3.8% |
| Drug Interaction |
3.8% |
| Gout |
3.8% |
| Hallucination, Visual |
3.8% |
| Inappropriate Antidiuretic Hormone Secretion |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Lobar Pneumonia |
3.8% |
| Multi-organ Failure |
3.8% |
| Myocardial Ischaemia |
3.8% |
| Nervousness |
3.8% |
| Ocular Hyperaemia |
3.8% |
| Pain |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
11.8% |
| Hypertension |
11.6% |
| Pain |
8.3% |
| Hypertonic Bladder |
7.4% |
| Prophylaxis |
5.7% |
| Drug Use For Unknown Indication |
4.9% |
| Depression |
4.7% |
| Insomnia |
4.7% |
| Vertigo |
4.7% |
| Parkinson's Disease |
4.4% |
| Benign Prostatic Hyperplasia |
4.1% |
| Osteoarthritis |
3.9% |
| Multiple Sclerosis |
3.6% |
| Constipation |
3.3% |
| Anxiety |
3.1% |
| Urinary Incontinence |
3.0% |
| Diabetes Mellitus |
2.8% |
| Cystitis |
2.7% |
| Nausea |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
|
| Pancreatitis |
16.7% |
| Death |
7.8% |
| Somnolence |
6.7% |
| Urinary Tract Infection |
6.7% |
| Hypersomnia |
5.6% |
| Pneumonia |
5.6% |
| Hyponatraemia |
4.4% |
| Myalgia |
4.4% |
| Renal Failure Acute |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Asthma |
3.3% |
| Clear Cell Carcinoma Of The Kidney |
3.3% |
| Gastroenteritis |
3.3% |
| Hypersensitivity |
3.3% |
| Injection Site Swelling |
3.3% |
| Osteonecrosis Of Jaw |
3.3% |
| Pain In Extremity |
3.3% |
| Palindromic Rheumatism |
3.3% |
| Pulmonary Embolism |
3.3% |
| Staphylococcal Sepsis |
3.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
90.0% |
| Atrial Fibrillation |
10.0% |
|
|
